Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.17B 1.02B 967M 878M 1.65B 113B 1.65B 11.58B 4.47B 57.29B 4.41B 4.31B 184B P/E 2026 *
23.6x
P/E 2027 * 12.1x
Enterprise Value 2.66B 2.32B 2.19B 1.99B 3.73B 256B 3.75B 26.27B 10.14B 130B 10.01B 9.78B 418B EV / Sales 2026 *
1.59x
EV / Sales 2027 * 1.42x
Free-Float
72.35%
Yield 2026 *
-
Yield 2027 * -
1 day-0.93%
1 week-3.35%
Current month-11.47%
1 month-14.64%
3 months-14.79%
6 months+68.31%
Current year+20.61%
1 week 14.9
Extreme 14.9
16.38
1 month 14.9
Extreme 14.9
18.37
Current year 8.7
Extreme 8.7
20.49
1 year 8.7
Extreme 8.7
20.49
3 years 8.7
Extreme 8.7
45.42
5 years 8.7
Extreme 8.7
74.98
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 30/04/2026
Director of Finance/CFO 54 27/06/2023
Chief Tech/Sci/R&D Officer - 16/02/2026
Director TitleAgeSince
Chairman 64 02/01/2012
Director/Board Member 81 31/12/1991
Director/Board Member 65 31/12/2005
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Tax

Head of Human Resources

-1,455 0.0019%
03/07/26 Tax

Chief Financial Officer

-5,226 0.0067%
01/07/26 Free

Executive/Senior Manager

5,590 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
-0.93%-3.35%-2.60%-61.84% 1.17B
+0.29%+0.51%-23.85%+1.46% 177B
-0.20%+1.73%-3.20%+11.75% 119B
+0.64%-3.39%+6.81%+73.52% 59.04B
-0.56%+1.43%-4.24%-31.82% 49.41B
-0.22%-2.29%+5.98%+35.20% 48.64B
+1.72%+7.43%+17.70%-6.40% 33.18B
-0.93%-2.09% - - 28.18B
-1.32%+4.86%+42.39%-7.99% 25.8B
+1.02%+5.99%+7.20%-19.54% 21.91B
Average -0.04%+1.04%+5.13%-0.63% 56.29B
Weighted average by Cap. +0.09%+0.35%-4.26%+9.75%

Financials

2026 *2027 *
Net sales 1.67B 1.46B 1.38B 1.25B 2.35B 161B 2.36B 16.51B 6.37B 81.69B 6.29B 6.15B 263B 1.73B 1.51B 1.42B 1.29B 2.42B 166B 2.43B 17.04B 6.58B 84.28B 6.49B 6.35B 271B
Net income 42.03M 36.65M 34.61M 31.43M 58.88M 4.03B 59.13M 415M 160M 2.05B 158M 154M 6.6B 78.69M 68.62M 64.79M 58.84M 110M 7.55B 111M 776M 300M 3.84B 296M 289M 12.35B
Net Debt 1.49B 1.3B 1.23B 1.11B 2.09B 143B 2.1B 14.69B 5.67B 72.66B 5.59B 5.47B 234B 1.28B 1.12B 1.06B 961M 1.8B 123B 1.81B 12.67B 4.89B 62.68B 4.83B 4.72B 202B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
18/09/26 US$14.99 -0.73% 369,704
17/09/26 US$15.10 -5.98% 1,051,358
16/09/26 US$16.06 +2.36% 1,618,120
15/09/26 US$15.69 -0.13% 1,077,647
14/09/26 US$15.71 +1.35% 1,141,852
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
15.10USD
Average target price
19.56USD
Spread / Average Target
+29.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!